Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725

Inflammation in atherosclerosis

Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129

CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein

Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996

Atherosclerosis

Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574

Atherogenesis and inflammation--was Virchow right?

Methe, H., & Weis, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm112 · Cited by 31

Impaired innate immune signaling due to combined Toll-like receptor 2 and 4 deficiency affects both periodontitis and atherosclerosis in response to polybacterial infection.

Chukkapalli, S. S., Ambadapadi, S., Varkoly, K., Jiron, J., Aguirre, J. I., Bhattacharyya, I., Morel, L. M., Lucas, A. R., & Lakshmyya, K. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty076 · Cited by 30

Monocyte Toll-Like Receptor Expression in Patients With Atrial Fibrillation

Gürses, K. M., Koçyiğit, D., Yalçın, M. U., Canpınar, H., Yorgun, H., ŞAHINER, L., Kaya, E. B., Oto, M. A., Ozer, N., Güç, D., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.02.014 · Cited by 30

Inflammation-induced mTORC2-Akt-mTORC1 signaling promotes macrophage foam cell formation

Banerjee, D., Sinha, A., Saikia, S., Gogoi, B., Rathore, A. K., Das, A. S., Pal, D., Buragohain, A. K., & Dasgupta, S. (2018) · Biochimie · doi:10.1016/j.biochi.2018.06.001 · Cited by 30

Molecular Mechanisms of Obesity and Diabetes: At the Intersection of Weight Regulation, Inflammation, and Glucose Homeostasis

O’Rourke, R. W. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0067-6 · Cited by 30

Toll-like receptors: a new target in rheumatoid arthritis?

Drexler, S. K., Sacre, S. M., & Foxwell, B. M. J. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.4.585 · Cited by 30

From Skeleton to Cytoskeleton

Yuen, C. Y., Wong, S. L., Lau, C. W., Tsang, S. Y., Xu, A., Zhu, Z., Ng, C., Yao, X., Kong, S. K., Lee, H. K., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.271361 · Cited by 30

The critical role of ABCG1 and PPARγ/LXRα signaling in TLR4 mediates inflammatory responses and lipid accumulation in vascular smooth muscle cells

Cao, X., Zhang, L., Chen, C., Wang, Q., Guo, L., Ma, Q., Deng, P., Zhu, G., Li, B., ., Y. P., et al. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2518-3 · Cited by 30

ATVB In Focus

Hansson, G. K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000153139.83149.a2 · Cited by 30

Is Type 2 Diabetes an Autoimmune-Inflammatory Disorder of the Innate Immune System?

Kohn, L. D., Wallace, B., Schwartz, F., & McCall, K. D. (2005) · Endocrinology · doi:10.1210/en.2005-0920 · Cited by 30

Adiponectin and Adaptive Immunity

Steffens, S., & Mach, F. (2008) · Circulation Research · doi:10.1161/circresaha.107.170274 · Cited by 30

The danger model: questioning an unconvincing theory

Józefowski, S. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.29 · Cited by 29

Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity

Das, D., & Podder, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104459 · Cited by 29

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis

Hoebinger, C., Rajcic, D., & Hendrikx, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.824481 · Cited by 32

Toll-like receptors 4 induces expression of matrix metalloproteinase-9 in human aortic smooth muscle cells

Li, H., Xu, H., & Liu, S. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0246-4 · Cited by 29

A central role for monocytes in Toll‐like receptor‐mediated activation of the vasculature

Ward, J. R., Francis, S., Marsden, L., Suddason, T., Lord, G. M., Dower, S., Crossman, D. C., & Sabroe, I. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03071.x · Cited by 29

The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling

Saxena, A., Rauch, U., Berg, K. E., Andersson, L., Hollender, L., Carlsson, A. M., Gomez, M. F., Hultgårdh‐Nilsson, A., Nilsson, J., & Björkbacka, H. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr075 · Cited by 29

Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose

Carnevale, R., Pastori, D., Nocella, C., Cammisotto, V., Baratta, F., Ben, M. D., Angelico, F., Sciarretta, S., Bartimoccia, S., Novo, M., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.06.007 · Cited by 29

Lipopolysaccharide regulates toll‐like receptor 4 expression in human aortic smooth muscle cells

Li, H., He, Y., Zhang, J., Sun, S., & Sun, B. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.01.034 · Cited by 29

Targeting the ACOD1-itaconate axis stabilizes atherosclerotic plaques

Harber, K. J., Neele, A. E., van Roomen, C. P. A. A., Gijbels, M. J., Beckers, L., den Toom, M., Schomakers, B. V., Heister, D., Willemsen, L., Griffith, G. R., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103054 · Cited by 28

Inflammatory Macrophage-Targeted Atherosclerosis Treatment by miRNA-Delivered, MRI-Visible, and Anti-Inflammatory Nanomedicine

Li, X., Chen, Y., Cao, X., Feng, W., Chen, Y., & Zhang, J. (2025) · ACS Nano · doi:10.1021/acsnano.4c16585 · Cited by 28

Multi-analyte profiling in human carotid atherosclerosis uncovers pro-inflammatory macrophage programming in plaques

Shalhoub, J., Viiri, L. E., Cross, A. J., Gregan, S. M., Allin, D., Astola, N., Franklin, I. J., Davies, A. H., & Monaco, C. G. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0650 · Cited by 28

DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages

Yang, K., Liu, X., Liu, Y., Wang, X., Cao, L., Zhang, X., Xu, C., Shen, W., & Zhou, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03740-7 · Cited by 28

Tanshinone IIA inhibits lipopolysaccharide‑induced inflammatory responses through the TLR4/TAK1/NF‑κB signaling pathway in vascular smooth muscle cells

Meng, Z., Si, C., Teng, S., Yu, X.-H., & Li, H. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4100 · Cited by 28

Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease

Shabbir, A., Rathod, K. S., Khambata, R. S., & Ahluwalia, A. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023229 · Cited by 29

Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells

de Groot, D., Hoefer, I. E., Grundmann, S., Schoneveld, A. H., Haverslag, R. T., van Keulen, J. K., Bot, P. T. G., Timmers, L., Piek, J. J., Pasterkamp, G., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.006 · Cited by 28

Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model

Wiciński, M., Malinowski, B., Węclewicz, M. M., Grześk, E., & Grześk, G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4180 · Cited by 28

Activation of estrogen receptor α inhibits TLR4 signaling in macrophages and alleviates the instability of atherosclerotic plaques in the postmenopausal stage

Meng, Q., Bi, Y., Feng, H., Ding, X., Zhang, S., Chen, Q., Wang, L., Zhang, Q., Li, Y., Tong, H., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109825 · Cited by 27

NOD1, a new player in cardiac function and calcium handling

Delgado, C., Ruiz‐Hurtado, G., Gómez‐Hurtado, N., González-Ramos, S., Rueda, A., Benito, G., Prieto, P., Zaragoza, C., Delicado, E. G., Pérez‐Sen, R., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv118 · Cited by 27

Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques

Wu, H., Cheng, X. W., Hu, L., Hao, C.-N., Hayashi, M., Takeshita, K., Hamrah, M. S., Shi, G., Kuzuya, M., & Murohara, T. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.098 · Cited by 27

A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice

Sorrentino, R., Yılmaz, A., Schubert, K., Crother, T. R., Pinto, A., Shimada, K., Arditi, M., & Chen, S. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.01.007 · Cited by 27

Atherosclerosis and Infection: Is the Jury Still Not In?

Chatzidimitriou, D., Kirmizis, D. A., Gavriilaki, E., Chatzidimitriou, M., & Malisiovas, N. (2012) · Future Microbiology · doi:10.2217/fmb.12.87 · Cited by 27

Oxidized Low-density Lipoprotein-induced Proinflammatory Cytokine Response in Macrophages are Suppressed by CD4+CD25+Foxp3+ Regulatory T Cells Through Downregulating Toll Like Receptor 2-mediated Activation of NF-ĸB

Li, M., Lin, J., Wang, Z., He, S., Ma, X., & Li, D. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315084 · Cited by 27

Activated TLR Signaling in Atherosclerosis among Women with Lower Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis

Huang, C., Liu, K., Pope, R. M., Du, P., Lin, S. M., Rajamannan, N. M., Huang, Q.-Q., Jafari, N., Burke, G. L., Post, W. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021067 · Cited by 29

Trypanosoma cruzi Infection Is a Potent Risk Factor for Non-alcoholic Steatohepatitis Enhancing Local and Systemic Inflammation Associated with Strong Oxidative Stress and Metabolic Disorders

Onofrio, L. I., Arocena, A. R., Paroli, A. F., Cabalén, M. E., Andrada, M. C., Cano, R. C., & Gea, S. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003464 · Cited by 27

Oxidized LDLs Inhibit TLR-induced IL-10 Production by Monocytes: A New Aspect of Pathogen-Accelerated Atherosclerosis

Bzowska, M., Nogieć, A., Skrzeczyńska-Moncznik, J., Mickowska, B., Guzik, K., & Pryjma, J. R. (2012) · Inflammation · doi:10.1007/s10753-012-9472-3 · Cited by 27

Role and therapeutic potential of gelsolin in atherosclerosis

Zhang, Q., Wen, X., Tang, S., Zhao, Z.-W., & Tang, C. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.03.012 · Cited by 26

Data Mining of Atherosclerotic Plaque Transcriptomes Predicts STAT1-Dependent Inflammatory Signal Integration in Vascular Disease

Sikorski, K., Wesoły, J., & Bluyssen, H. A. R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150814313 · Cited by 26

Nuclear Transport Modulation Reduces Hypercholesterolemia, Atherosclerosis, and Fatty Liver

Liu, Y., Major, A. S., Zienkiewicz, J., Gabriel, C. L., Veach, R. A., Moore, D. J., Collins, R. D., & Hawiger, J. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000093 · Cited by 26

Accumulation of Stimulants of Toll‐Like Receptor (TLR)‐2 and TLR4 in Meat Products Stored at 5 °C

Erridge, C. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.02018.x · Cited by 26

Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation

Lundberg, A. M., & Yan, Z.-Q. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834ada80 · Cited by 26

Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?

Katsargyris, Α., Klonaris, C. N., Bastounis, E., & Theocharis, S. E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1329 · Cited by 26

Inflammation in Atherosclerosis

Lauterbach, M., Labzin, L. I., & Latz, E. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch49 · Cited by 26

Toll-like receptor 3 mediates expression of clusterin/apolipoprotein J in vascular smooth muscle cells stimulated with RNA released from necrotic cells

Baiersdörfer, M., Schwarz, M., Seehafer, K., Lehmann, C. H. K., Heit, A., Wagner, H., Kirschning, C. J., & Koch-Brandt, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.07.022 · Cited by 27

Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota

Latteri, S., Sofia, M., Puleo, S., Vincenzo, A. D., Cinti, S., & Castorina, S. (2023) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-023-02821-8 · Cited by 25

Microbial Sensing by Toll Receptors

Chtarbanova, S., & Imler, J. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179523 · Cited by 25

Toll-like receptor 4 expressions on peripheral blood monocytes were enhanced in coronary artery disease even in patients with low C-reactive protein

Shiraki, R., Inoue, N., Kobayashi, S., Ejiri, J., Otsui, K., Honjo, T., Takahashi, M., Hirata, K., Yokoyama, M., & Kawashima, S. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.08.027 · Cited by 25

An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation

Karper, J. C., de Jager, S. C. A., Ewing, M. M., de Vries, M. R., Bot, I., van Santbrink, P. J., Redeker, A., Mallat, Z., Binder, C. J., Arens, R., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301882 · Cited by 25

The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells

Arnott, C. G., Punnia-Moorthy, G., Tan, J. T. M., Sadeghipour, S., Bursill, C. A., & Patel, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150688 · Cited by 25

Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells

Suzuki, K., Ohkuma, M., & Nagaoka, I. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4294 · Cited by 25

Minor C allele of the SNP rs7873784 associated with rheumatoid arthritis and type-2 diabetes mellitus binds PU.1 and enhances TLR4 expression.

Korneev, K. V., Sviriaeva, E. N., Mitkin, N. A., Gorbacheva, A. M., Uvarova, A. N., Ustiugova, A. S., Polanovsky, O. L., Kulakovskiy, I. V., Afanasyeva, M. A., Schwartz, A. M., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165626 · Cited by 25

Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study

Bielinski, S. J., Hall, J. L., Pankow, J. S., Boerwinkle, E., Matijevic‐Aleksic, N., He, M. M., Chambless, L. E., & Folsom, A. R. (2011) · Human Genetics · doi:10.1007/s00439-011-0962-4 · Cited by 25

Toll-Like Receptors

Erickson, B., Sperber, K. E., & Frishman, W. H. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e3181709fd8 · Cited by 25

Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis

Chen, L., Ishigami, T., Doi, H., Arakawa, K., & Tamura, K. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01936-5 · Cited by 24

Corilagin Ameliorates Atherosclerosis in Peripheral Artery Disease via the Toll-Like Receptor-4 Signaling Pathway in vitro and in vivo

Li, Y., Wang, Y., Chen, Y., Wang, Y., Zhang, S., Liu, P., Chen, Z., Song, P., Luo, L., Luo, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01611 · Cited by 24

Targeting Inflammation in Cardiovascular Diseases. Still a Neglected field?

Gómez‐Guerrero, C., Mallavia, B., & Egido, J. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00274.x · Cited by 24

Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation

Mukhopadhyay, R. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0134-4 · Cited by 24

Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice

Andoh, Y., Ogura, H., Satoh, M., Shimano, K., Okuno, H., Fujii, S., Ishimori, N., Eshima, K., Tamauchi, H., Otani, T., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.022 · Cited by 24

Role of Toll-Like Receptor 4 on Lupus Lung Injury and Atherosclerosis in LPS-Challenge ApoE −/− Mice

Ni, J., Ouyang, Q., Lin, L., Huang, Z., Lu, H., Chen, X., Lin, H., Wang, Z., Xu, D., & Zhang, Y. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/476856 · Cited by 24

Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis

Liu, C.-L., Santos, M. M., Fernandes, C. R., Liao, M., Iamarene, K., Zhang, J., Sukhova, G. K., & Shi, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-00977-0 · Cited by 24

Toll-Like Receptor Signaling: Emerging Opportunities in Human Diseases and Medicine

Bhattacharjee, R. N., & Akira, S. (2005) · Current Immunology Reviews · doi:10.2174/1573395052952897 · Cited by 24

Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming

Aronova, A., Tosato, F., Naser, N., & Asare, Y. (2023) · Cells · doi:10.3390/cells12192359 · Cited by 24

Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans

Stachon, P., Missiou, A., Walter, C., Varo, N., Colberg, C., Wolf, D., Buchner, M., Mühlen, C. V. Z., Zirlik, K., Bode, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011589 · Cited by 23

Enhanced Anti-Inflammatory Activities of Monascus pilosus Fermented Products by Addition of Ginger to the Medium

Chen, C., Chyau, C.-C., Liao, C.-C., Hu, T.-J., & Kuo, C.-F. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf103070m · Cited by 23

Myrtenol alleviates oxidative stress and inflammation in diabetic pregnant rats via TLR4/MyD88/NF‐κB signaling pathway

Xuemei, L., Qiu, S., Chen, G., & Liu, M. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22904 · Cited by 23

Amelioration of Atherosclerosis by lycopene is linked to the modulation of gut microbiota dysbiosis and related gut-heart axis activation in high-fat diet-fed ApoE−/− mice

Tu, T., Liu, H., Liu, Z., Liang, Y., Tan, C., Feng, D., & Zou, J. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00772-x · Cited by 24

Probucol Attenuates Inflammation and Increases Stability of Vulnerable Atherosclerotic Plaques in Rabbits

Li, T., Chen, W., An, F., Tian, H., Zhang, J., Peng, J., Zhang, Y., & Guo, Y. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.225.23 · Cited by 23

Increased Expression of NLRP3 Inflammasome in Wall of Ruptured and Unruptured Human Cerebral Aneurysms: Preliminary Results

Zhang, D.-D., Yan, H., Hu, Y., Zhuang, Z., Zhuang, Y., & Hang, C. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.12.019 · Cited by 23

Nutritional status, genetic susceptibility, and insulin resistance—important precedents to atherosclerosis

McGillicuddy, F. C., & Roche, H. M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100785 · Cited by 23

The hemostatic system as a regulator of inflammation in atherosclerosis

Koch, M., & Zernecke, A. (2014) · IUBMB Life · doi:10.1002/iub.1333 · Cited by 23

Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques

Katsargyris, Α., Theocharis, S. E., Tsiodras, S., Giaginis, C., Bastounis, E., & Klonaris, C. N. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903401294 · Cited by 23

Immune-mediated and lipid-mediated platelet function in atherosclerosis

Ahmadsei, M., Lievens, D., Weber, C., von Hundelshausen, P., & Gerdes, N. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000212 · Cited by 23

PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)

Regidor, P., de la Rosa, X., Müller, A., Mayr, M., Santos, F. G., Banzo, R. G., & Rizo, J. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020456 · Cited by 22

Cholesterol, Inflammasomes, and Atherogenesis

Ordovás, J. M., & Ordovás-Montañés, J. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0212-2 · Cited by 22

Curcumin affects ox‑LDL‑induced IL‑6, TNF‑α, MCP‑1 secretion and cholesterol efflux in THP‑1 cells by suppressing the TLR4/NF‑κB/miR33a signaling pathway

田中, 義., Liu, C., Feng, J., Li, J., & Fan, Z. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8915 · Cited by 22

Comprehensive functional core microbiome comparison in genetically obese and lean hosts under the same environment

Martínez-Álvaro, M., Zubiri-Gaitán, A., Hernández, P., Greenacre, M. J., Ferrer, A., & Blasco, A. (2021) · Communications Biology · doi:10.1038/s42003-021-02784-w · Cited by 23

IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux

Rana, M., Kumar, A., Tiwari, R. L., Singh, V., Chandra, T., Dikshit, M., & Barthwal, M. K. (2016) · BioEssays · doi:10.1002/bies.201600085 · Cited by 22

Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation

Kim, J., Kim, J., Byeon, H.-E., Kim, J.-W., Kim, H., Suh, C., Choi, S., Linton, M. F., & Jung, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126808 · Cited by 23

Trem2/Tyrobp Signaling Protects Against Aortic Dissection and Rupture by Inhibiting Macrophage Activation in Mice

Zhang, Z., Wu, M., Yao, L., Zhou, W., Liu, X., Chen, Z., Hua, P., Xu, L., Lv, L., Liu, C.-Y., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321429 · Cited by 21

The alarmin tandem: unraveling the complex effect of S100A8/A9 – from atherosclerosis to cardiac arrhythmias

Cozac, D. A., Halațiu, V.-B., & Scridon, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1630410 · Cited by 22

Modification of pro‐inflammatory signaling by dietary components: The plasma membrane as a target

Ciesielska, A., & Kwiatkowska, K. (2015) · BioEssays · doi:10.1002/bies.201500017 · Cited by 23

Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness

Ellenbroek, G. H. J. M., van Puijvelde, G. H. M., Anas, A. A., Bot, M., Asbach, M., Schoneveld, A. H., van Santbrink, P. J., Foks, A. C., Timmers, L., Doevendans, P. A., et al. (2017) · Scientific Reports · doi:10.1038/srep42688 · Cited by 21

RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy

Olejarz, W., Łacheta, D., Głuszko, A., Migacz, E., Kukwa, W., Szczepański, M. J., Tomaszewski, P., & Nowicka, G. (2018) · BioMed Research International · doi:10.1155/2018/7675286 · Cited by 21

The truncated MyD88s negatively regulates TLR2 signal on expression of IL17-1 in oyster Crassostrea gigas

Fan, S., Wang, W., Li, J., Cao, W., Li, Q., Wu, S., Wang, L., & Song, L. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104446 · Cited by 20

Fibronectin containing alternatively spliced extra domain A interacts at the central and c-terminal domain of Toll-like receptor-4

Gupta, S., Ali, A., Pandey, S., Khan, I. A., & Prakash, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-13622-2 · Cited by 20

The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites

Lu, D., Zou, X., & Zhang, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.948755 · Cited by 20

Emerging Role of Chemokine Receptor 7 in Atherosclerosis

Schieffer, B., & Luchtefeld, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.05.012 · Cited by 21

NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs

Al-Hawary, S. I. S., Jasim, S. A., Romero‐Parra, R. M., Bustani, G. S., Hjazi, A. M., Alghamdi, M., Kareem, A. K., Alwaily, E. R., Zabibah, R. S., Gupta, J., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154490 · Cited by 20

Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway

Ouyang, Q., Huang, Z., Lin, H., Ni, J., Lu, H., CHEN, X., Wang, Z., & Lin, L. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3774 · Cited by 19

Inflammatory and Autoimmune Reactions in Atherosclerosis and Vaccine Design Informatics

Jan, M., Meng, S., Chen, N. C., Mai, J., Wang, H., & Yang, X. (2010) · BioMed Research International · doi:10.1155/2010/459798 · Cited by 19

Apolipoprotein E-knockout mice show increased titers of serum anti-nuclear and anti-dsDNA antibodies

Wang, Y., Huang, Z., Lu, H., Lin, H., Wang, Z., Chen, X., Ouyang, Q., Tang, M., Hao, P., Ni, J., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.044 · Cited by 19

The effect of lysophosphatidic acid on Toll-like receptor 4 expression and the nuclear factor-κB signaling pathway in THP-1 cells

Yang, B., Zhou, Z., Li, X., & Niu, J. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2804-0 · Cited by 19

Immunological mechanisms underlying sterile inflammation in the pathogenesis of atherosclerosis: potential sites for intervention

Truong, R., Thankam, F. G., & Agrawal, D. K. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1860757 · Cited by 18

Nucleotide-Binding Oligomerization Domain Protein 2 Deficiency Enhances Neointimal Formation in Response to Vascular Injury

Kwon, M.-Y., Liu, X., Lee, S., Kang, Y.-H., Choi, A. M. K., Lee, K., Perrella, M. A., & Chung, S. W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.235135 · Cited by 18

Implication of Pattern-Recognition Receptors in Cardiovascular Diseases

Wang, X., & Yi, F. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6184 · Cited by 18

Nutrigenomics and Proteomics in Health and Disease

Mine, Y., Miyashita, K., & Shahidi, F. (2009) · Wiley eBooks · doi:10.1002/9780813807263 · Cited by 18

Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice

Aini, K., Fukuda, D., Tanaka, K., Higashikuni, Y., Hirata, Y., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., & Sata, M. (2019) · International Heart Journal · doi:10.1536/ihj.19-117 · Cited by 18

Toll-Like Receptor 2/6 Agonist Macrophage-Activating Lipopeptide-2 Promotes Reendothelialization and Inhibits Neointima Formation After Vascular Injury

Grote, K., Sonnenschein, K., Kapopara, P. R., Hillmer, A., Grothusen, C., Salguero, G., Kotlarz, D., Schuett, H., Bavendiek, U., & Schieffer, B. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301799 · Cited by 18

Toll-like Receptor 4 Stimulates Gene Expression via Smad2 Linker Region Phosphorylation in Vascular Smooth Muscle Cells

Afroz, R., Zhou, Y., Little, P. J., Xu, S., Mohamed, R., Stow, J. L., & Kamato, D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00113 · Cited by 18

Protective Role for Toll-Like Receptor-9 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice

Koulis, C., Chen, Y., Hausding, C., Ahrens, I., Kyaw, T. S., Tay, C., Allen, T. J., Jandeleit-Dahm, K. A. M., Sweet, M. J., Akira, S., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302407 · Cited by 80

Platelet Factor 4 and Toll-Like Receptor 2 are Expressed in Atherosclerotic Plaques of Apolipoprotein E~(-/-)Mice

Hai, J. (2007) · Chinese Journal of Arteriosclerosis

Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis

Chen, S., Shimada, K., Crother, T. R., Erbay, E., Shah, P. K., & Arditi, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.072 · Cited by 32

Toll-like receptor signaling and atherosclerosis

Michelsen, K. S., & Arditi, M. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219662.88409.7c · Cited by 42

Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient Mice

Higashimori, M., Tatro, J. B., Moore, K. J., Mendelsohn, M. E., Galper, J., & Beasley, D. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.210971 · Cited by 125